Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.440
-0.050 (-1.43%)
At close: Nov 20, 2024, 4:00 PM
3.549
+0.109 (3.18%)
After-hours: Nov 20, 2024, 5:04 PM EST
Arbutus Biopharma Employees
Arbutus Biopharma had 73 employees as of December 31, 2023. The number of employees decreased by 25 or -25.51% compared to the previous year.
Employees
73
Change (1Y)
-25
Growth (1Y)
-25.51%
Revenue / Employee
$92,356
Profits / Employee
-$1,050,685
Market Cap
651.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InnovAge Holding | 2,350 |
agilon health | 1,117 |
Adaptive Biotechnologies | 709 |
Ironwood Pharmaceuticals | 267 |
Prothena Corporation | 173 |
IRADIMED CORPORATION | 148 |
CorMedix | 83 |
Dianthus Therapeutics | 53 |
ABUS News
- 5 days ago - Arbutus' Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - GlobeNewsWire
- 6 days ago - Arbutus to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 14 days ago - Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 5 weeks ago - Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024 - GlobeNewsWire
- 2 months ago - Arbutus to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Arbutus Biopharma Corporation (ABUS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire